RxDoctor Payments Data

Cheree Eldridge

Podiatrist · Lawrenceville, GANPI 1891059887

Payments from drug & device makers

What this record shows

5 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 52.8% of the total. Reporting peaked in 2021 at $939 and has fallen 81.9% since, to $170 in 2025.

$1,701in general payments, 2019–2025

Across 22 payments — averaging $77.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$898
  • Smith+Nephew$563
  • Melinta Therapeutics, LLC$118
  • Convatec Inc.$110
  • Amgen$13

What the payments were for

  • Travel & lodging$75044%
  • Food & beverage$95156%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,701 in reported general payments places this provider in the 55th percentile of 177 podiatrist providers in Georgia.

See all podiatrist providers in Georgia

Medicare billing

Part B allowed, 2024
$102,913
Medicare patients
815
Services billed
3,190

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox34$813
Ketoconazole34$681
Doxycycline Hyclate20$160
Mupirocin19$144
Methylprednisolone24$136
Meloxicam15$50

Paid to pharmacies, not to this prescriber.

Other podiatrist in Lawrenceville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →